Press Releases

Newsroom
In the News
Press Releases
Resources for Journalists

Press Releases

Share
Share
and/or
493 News Releases found
MSK Awards & Appointments July 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:
MSK's 1275 York Ave location
Memorial Sloan Kettering Cancer Center Ranked Among the Best Hospitals for Cancer Care by U.S. News & World Report for 33 Consecutive Years

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing. Since these prestigious rankings were established more than 30 years ago, MSK has consistently ranked among the top two cancer hospitals in the country.
MSK Commack
A Gift in Memory of "Nonna": Memorial Sloan Kettering Cancer Center and the Nonna's Garden Foundation Celebrate Major Gift on Long Island

Memorial Sloan Kettering established The Nonna's Garden Foundation Initiative for Cancer Care and Research and recently renamed its first freestanding regional location on Long Island, following a generous $50 million gift from Mike and Maria Repole and the Nonna's Garden Foundation.
Dr. Selwyn M. Vickers
Dr. Selwyn M. Vickers Named President and CEO of Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has been selected to serve as its next President and Chief Executive Officer.
MSK Awards & Appointments June 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Luis Alberto Diaz, Jr., MD and Andrea Cercek, MD
ASCO 2022: 100% Complete Response Rate in MMRd Locally Advanced Rectal Cancer Seen in Pivotal ‘Immunoablative’ Neoadjuvant Immunotherapy Clinical Trial

Breakthrough findings were presented at the 2022 ASCO Annual Meeting and published in The New England Journal of Medicine today by researchers at Memorial Sloan Kettering Cancer Center (MSK) confirming a clinical complete response in all 14 patients who received the immunotherapy treatment dostarlimab as a first-line treatment for mismatch repair-deficient (MMRd) locally advanced rectal cancer. This new approach of “immunoablative” therapy uses immunotherapy to replace surgery, chemotherapy and radiation to remove cancer.
Shanu Modi
ASCO 2022: Practice-Changing Findings Identify HER2-Low as a Targetable Subset of Breast Cancer, Redefining Treatment for More Than 60 Percent of HER2-Negative Metastatic Breast Cancer Patients

New data from researchers at MSK featured in the 2022 ASCO Annual Meeting press program and simultaneously published in The New England Journal of Medicine highlights a novel antibody-drug conjugate that doubled progression-free survival in HER2-low metastatic breast cancer.
Cancer Care Closer to Home: Physicians of Memorial Sloan Kettering Cancer Center and New York Cancer & Blood Specialists to Open New Cancer Care Facility in Brooklyn

Memorial Sloan Kettering Cancer Center (MSK) and New York Cancer & Blood Specialists (NYCBS), one of the fastest-growing community oncology practices in the nation, today announced plans to open a 39,000 sq ft facility in Brooklyn, New York, in early 2023.
Shanu Modi, MD, Andrea Cercek, MD, Vinod Balachandran, MD, and Jonathan Yang, MD, PhD
ASCO 2022: Memorial Sloan Kettering Cancer Center Experts To Present Significant Research at the American Society of Clinical Oncology Annual Meeting

Physicians and scientists from MSK will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2022 ASCO Annual Meeting, June 3–7 in Chicago.
MSK Awards & Appointments May 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: